| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB4 ERBB3 ERN1 SCYL1 HUNK PHKA2 MAPK12 MAP3K15 POLR1A POLE2 ADCK1 POLRMT MAGI3 ACVR1C PAPSS2 POLR3A TGFBR1 RNASEL CSNK2A1 CSNK2A2 DGKK PRKCI MAP2K2 CSNK2A3 | 1.33e-05 | 938 | 193 | 24 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | EPHB4 ERBB3 ERN1 SCYL1 HUNK PHKA2 MAPK12 MAP3K15 ADCK1 MAGI3 ACVR1C PAPSS2 TGFBR1 RNASEL CSNK2A1 CSNK2A2 DGKK PRKCI MAP2K2 CSNK2A3 | 5.35e-05 | 764 | 193 | 20 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB4 ERBB3 ERN1 SCYL1 HUNK PHKA2 MAPK12 MAP3K15 ADCK1 ACVR1C PAPSS2 TGFBR1 RNASEL CSNK2A1 CSNK2A2 DGKK PRKCI MAP2K2 CSNK2A3 | 6.09e-05 | 709 | 193 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB4 ERBB3 ERN1 SCYL1 HUNK PHKA2 MAPK12 MAP3K15 ADCK1 ACVR1C TGFBR1 RNASEL CSNK2A1 CSNK2A2 PRKCI MAP2K2 CSNK2A3 | 7.70e-05 | 600 | 193 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | Rho GDP-dissociation inhibitor activity | 2.77e-04 | 3 | 193 | 2 | GO:0005094 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | ERN1 HUNK PHKA2 MAPK12 MAP3K15 ADCK1 ACVR1C TGFBR1 CSNK2A1 CSNK2A2 PRKCI MAP2K2 CSNK2A3 | 4.17e-04 | 446 | 193 | 13 | GO:0004674 |
| GeneOntologyBiologicalProcess | glucose catabolic process | 1.09e-05 | 32 | 192 | 5 | GO:0006007 | |
| GeneOntologyCellularComponent | protein kinase CK2 complex | 3.13e-06 | 4 | 194 | 3 | GO:0005956 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | ERN1 PHKA2 POLR1A LEO1 POLE2 POLRMT ACVR1C POLR3A TGFBR1 CSNK2A1 CSNK2A2 PRKCI CSNK2A3 | 1.59e-05 | 335 | 194 | 13 | GO:0061695 |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.12e-04 | 157 | 194 | 8 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 1.94e-04 | 170 | 194 | 8 | GO:1902911 | |
| GeneOntologyCellularComponent | transferase complex | ERN1 KDM6B PHKA2 FBXW8 PIGA FBXO39 MED17 USP47 PDSS2 OGT POLR1A LEO1 POLE2 POLRMT ACVR1C POLR3A TGFBR1 CSNK2A1 CSNK2A2 PRKCI CSNK2A3 | 2.53e-04 | 963 | 194 | 21 | GO:1990234 |
| Domain | Prot_kinase_dom | EPHB4 ERBB3 ERN1 SCYL1 HUNK MAPK12 MAP3K15 MARVELD3 ADCK1 ACVR1C TGFBR1 RNASEL CSNK2A1 CSNK2A2 PRKCI MAP2K2 CSNK2A3 | 1.36e-05 | 489 | 193 | 17 | IPR000719 |
| Domain | Kinase-like_dom | EPHB4 ERBB3 ERN1 SCYL1 HUNK DST MAPK12 MAP3K15 ADCK1 ACVR1C TGFBR1 RNASEL CSNK2A1 CSNK2A2 MACF1 PRKCI MAP2K2 CSNK2A3 | 1.39e-05 | 542 | 193 | 18 | IPR011009 |
| Domain | PROTEIN_KINASE_DOM | EPHB4 ERBB3 ERN1 SCYL1 HUNK MAPK12 MAP3K15 ADCK1 ACVR1C TGFBR1 RNASEL CSNK2A1 CSNK2A2 PRKCI MAP2K2 CSNK2A3 | 5.60e-05 | 493 | 193 | 16 | PS50011 |
| Domain | CH | 5.61e-05 | 65 | 193 | 6 | SM00033 | |
| Domain | ACTININ_2 | 8.39e-05 | 23 | 193 | 4 | PS00020 | |
| Domain | ACTININ_1 | 8.39e-05 | 23 | 193 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.39e-05 | 23 | 193 | 4 | IPR001589 | |
| Domain | CH | 8.53e-05 | 70 | 193 | 6 | PF00307 | |
| Domain | PROTEIN_KINASE_ATP | EPHB4 ERBB3 ERN1 HUNK MAPK12 MAP3K15 ADCK1 ACVR1C TGFBR1 RNASEL CSNK2A1 CSNK2A2 PRKCI MAP2K2 CSNK2A3 | 8.89e-05 | 459 | 193 | 15 | PS00107 |
| Domain | - | 9.24e-05 | 71 | 193 | 6 | 1.10.418.10 | |
| Domain | PIEZO | 1.06e-04 | 2 | 193 | 2 | PF15917 | |
| Domain | Piezo | 1.06e-04 | 2 | 193 | 2 | IPR027272 | |
| Domain | Piezo_RRas_bdg | 1.06e-04 | 2 | 193 | 2 | PF12166 | |
| Domain | Piezo_RRas-bd_dom | 1.06e-04 | 2 | 193 | 2 | IPR031334 | |
| Domain | Piezo_dom | 1.06e-04 | 2 | 193 | 2 | IPR031805 | |
| Domain | CH | 1.08e-04 | 73 | 193 | 6 | PS50021 | |
| Domain | CH-domain | 1.25e-04 | 75 | 193 | 6 | IPR001715 | |
| Domain | Pkinase | ERN1 SCYL1 HUNK MAPK12 MAP3K15 ACVR1C TGFBR1 RNASEL CSNK2A1 CSNK2A2 PRKCI MAP2K2 CSNK2A3 | 1.73e-04 | 381 | 193 | 13 | PF00069 |
| Domain | RNA_pol_Rpb1_2 | 3.17e-04 | 3 | 193 | 2 | PF00623 | |
| Domain | RhoGDI_domain | 3.17e-04 | 3 | 193 | 2 | IPR024792 | |
| Domain | RNA_pol_asu | 3.17e-04 | 3 | 193 | 2 | IPR000722 | |
| Domain | KEN_dom | 3.17e-04 | 3 | 193 | 2 | IPR010513 | |
| Domain | RNA_pol_N | 3.17e-04 | 3 | 193 | 2 | IPR006592 | |
| Domain | Rho_GDI | 3.17e-04 | 3 | 193 | 2 | PF02115 | |
| Domain | RNA_pol_Rpb1_1 | 3.17e-04 | 3 | 193 | 2 | PF04997 | |
| Domain | RNA_pol_Rpb1_5 | 3.17e-04 | 3 | 193 | 2 | PF04998 | |
| Domain | RNA_pol_Rpb1_3 | 3.17e-04 | 3 | 193 | 2 | PF04983 | |
| Domain | RNA_pol_Rpb1_4 | 3.17e-04 | 3 | 193 | 2 | PF05000 | |
| Domain | - | 3.17e-04 | 3 | 193 | 2 | 2.70.50.30 | |
| Domain | RPOLA_N | 3.17e-04 | 3 | 193 | 2 | SM00663 | |
| Domain | RNA_pol_Rpb1_4 | 3.17e-04 | 3 | 193 | 2 | IPR007083 | |
| Domain | RNA_pol_Rpb1_5 | 3.17e-04 | 3 | 193 | 2 | IPR007081 | |
| Domain | RNA_pol_Rpb1_1 | 3.17e-04 | 3 | 193 | 2 | IPR007080 | |
| Domain | Ribonuc_2-5A | 3.17e-04 | 3 | 193 | 2 | PF06479 | |
| Domain | RNA_pol_Rpb1_3 | 3.17e-04 | 3 | 193 | 2 | IPR007066 | |
| Domain | Rho_GDI | 3.17e-04 | 3 | 193 | 2 | IPR000406 | |
| Domain | KEN | 3.17e-04 | 3 | 193 | 2 | PS51392 | |
| Domain | S_TKc | ERN1 HUNK MAPK12 MAP3K15 ACVR1C TGFBR1 RNASEL CSNK2A1 CSNK2A2 PRKCI MAP2K2 CSNK2A3 | 3.71e-04 | 359 | 193 | 12 | SM00220 |
| Domain | Nebulin | 6.29e-04 | 4 | 193 | 2 | PF00880 | |
| Domain | DUF1736 | 6.29e-04 | 4 | 193 | 2 | IPR013618 | |
| Domain | NEBULIN | 6.29e-04 | 4 | 193 | 2 | PS51216 | |
| Domain | NEBU | 6.29e-04 | 4 | 193 | 2 | SM00227 | |
| Domain | Nebulin | 6.29e-04 | 4 | 193 | 2 | IPR013998 | |
| Domain | Nebulin_repeat | 6.29e-04 | 4 | 193 | 2 | IPR000900 | |
| Domain | DUF1736 | 6.29e-04 | 4 | 193 | 2 | PF08409 | |
| Domain | PUG | 1.04e-03 | 5 | 193 | 2 | SM00580 | |
| Domain | Ser/Thr_kinase_AS | ERN1 HUNK MAPK12 MAP3K15 ACVR1C TGFBR1 CSNK2A1 CSNK2A2 PRKCI MAP2K2 CSNK2A3 | 1.26e-03 | 357 | 193 | 11 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | ERN1 HUNK MAPK12 MAP3K15 ACVR1C TGFBR1 CSNK2A1 CSNK2A2 PRKCI MAP2K2 CSNK2A3 | 1.40e-03 | 362 | 193 | 11 | PS00108 |
| Domain | - | 1.55e-03 | 6 | 193 | 2 | 3.90.1290.10 | |
| Domain | GAR | 1.55e-03 | 6 | 193 | 2 | PS51460 | |
| Domain | PUB_domain | 1.55e-03 | 6 | 193 | 2 | IPR018997 | |
| Domain | GAS2 | 1.55e-03 | 6 | 193 | 2 | PF02187 | |
| Domain | - | 1.55e-03 | 6 | 193 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.55e-03 | 6 | 193 | 2 | IPR003108 | |
| Domain | GAS2 | 1.55e-03 | 6 | 193 | 2 | SM00243 | |
| Domain | Spectrin | 1.65e-03 | 23 | 193 | 3 | PF00435 | |
| Domain | Pentatricopeptide_repeat | 1.65e-03 | 23 | 193 | 3 | IPR002885 | |
| Domain | Protein_kinase_ATP_BS | EPHB4 HUNK MAPK12 MAP3K15 ACVR1C TGFBR1 CSNK2A1 CSNK2A2 PRKCI MAP2K2 CSNK2A3 | 2.01e-03 | 379 | 193 | 11 | IPR017441 |
| Domain | GS_dom | 2.16e-03 | 7 | 193 | 2 | IPR003605 | |
| Domain | GS | 2.16e-03 | 7 | 193 | 2 | PS51256 | |
| Domain | Plectin | 2.16e-03 | 7 | 193 | 2 | PF00681 | |
| Domain | TGF_beta_GS | 2.16e-03 | 7 | 193 | 2 | PF08515 | |
| Domain | GS | 2.16e-03 | 7 | 193 | 2 | SM00467 | |
| Domain | Plectin_repeat | 2.16e-03 | 7 | 193 | 2 | IPR001101 | |
| Domain | PLEC | 2.16e-03 | 7 | 193 | 2 | SM00250 | |
| Domain | TPR_8 | 2.18e-03 | 53 | 193 | 4 | PF13181 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 1.40e-06 | 19 | 152 | 5 | MM15113 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 2.42e-06 | 21 | 152 | 5 | M878 | |
| Pathway | REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL | 6.62e-05 | 8 | 152 | 3 | M27100 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 8.98e-05 | 68 | 152 | 6 | MM14968 | |
| Pathway | REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL | 9.84e-05 | 9 | 152 | 3 | MM14792 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DDX19A RPL29 STRBP ZNF318 ADAR XAB2 ABCB1 FASN FBXW8 DST UTP20 FLNC MYBBP1A POLR1A IARS1 SHMT2 SPECC1 SLC3A2 KIF7 ARHGDIA LSR LRPPRC RRP9 CSNK2A1 MACF1 | 8.78e-10 | 1024 | 196 | 25 | 24711643 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAGEA1 DDX19A RPL29 ADAR FASN DST SBF1 BYSL AP1M1 UTP20 PGP FLNC MYBBP1A MRPS28 POLR1A IARS1 POLRMT SHMT2 RFC4 PAPSS2 POLR3A SLC3A2 ARHGDIA NSUN5 LRPPRC ARAP3 SLC25A12 MACF1 | 3.09e-09 | 1353 | 196 | 28 | 29467282 |
| Pubmed | STRBP ZNF318 XAB2 FASN DST SBF1 BYSL UTP20 USP47 FLNC MYBBP1A POLR1A POLRMT ARHGDIA LRPPRC RRP9 CSNK2A1 CSNK2A2 MACF1 | 6.62e-09 | 653 | 196 | 19 | 22586326 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | IQGAP2 STRBP ADAR PHKA2 FASN FBXW8 CFDP1 UTP20 USP47 FOXJ1 FLNC OGT IARS1 DVL2 POLRMT KIF7 ORC2 RNASEL SIX5 CHSY3 SPIDR | 2.02e-08 | 857 | 196 | 21 | 25609649 |
| Pubmed | ERBB3 STRBP XAB2 PHKA2 DST SBF1 AP1M1 OGT LEO1 ANGEL1 POLRMT PAPSS2 POLR3A TGFBI GRPEL1 ARAP3 PRKCI PLCH1 | 3.57e-08 | 650 | 196 | 18 | 38777146 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | XAB2 DST SUPT4H1 UTP20 MED17 DOCK2 MYBBP1A POLR1A IARS1 POLRMT OPA1 POLR3A GRPEL1 SLC25A12 PRKCI | 5.38e-08 | 454 | 196 | 15 | 33226137 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DDX19A FASN SBF1 PUS7 USP47 FLNC OGT LEO1 POLE2 POLRMT SHMT2 IDE OPA1 SLC3A2 KIF7 LSR LRPPRC ARAP3 CSNK2A1 CSNK2A2 PNMA2 | 1.73e-07 | 974 | 196 | 21 | 28675297 |
| Pubmed | 1.76e-07 | 3 | 196 | 3 | 2174700 | ||
| Pubmed | Phosphorylation of the Spi-B transcription factor reduces its intrinsic stability. | 1.76e-07 | 3 | 196 | 3 | 10618498 | |
| Pubmed | 1.76e-07 | 3 | 196 | 3 | 1766873 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | DST SBF1 MED17 USP47 POLRMT KIF7 LRPPRC SLC25A12 ARID2 IQCB1 | 3.91e-07 | 212 | 196 | 10 | 33853758 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | IQGAP2 ADAR FASN MYBBP1A MRPS28 IARS1 POLRMT RFC4 LRPPRC SLC25A12 | 5.72e-07 | 221 | 196 | 10 | 29991511 |
| Pubmed | DDX19A RPL29 ACAA1 LPCAT4 SCYL1 ADAR XAB2 FASN PIGA BYSL AP1M1 MED17 DOCK2 MYBBP1A IARS1 RNF213 OPA1 POLR3A SLC3A2 ORC2 LRPPRC GUSB | 8.44e-07 | 1168 | 196 | 22 | 19946888 | |
| Pubmed | ITGAV DST SBF1 FCHO2 SPECC1 OPA1 SLC3A2 LSR LRPPRC GUSB MACF1 PRKCI PLCH1 | 9.09e-07 | 421 | 196 | 13 | 36976175 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MAGEA1 RPL29 STRBP SQLE ADAR XAB2 FASN SUPT4H1 BYSL UTP20 FLNC MYBBP1A SHMT2 RFC4 SLC3A2 NSUN5 LRPPRC RRP9 CSNK2A1 CSNK2A2 | 9.34e-07 | 989 | 196 | 20 | 36424410 |
| Pubmed | PSD ASH1L LPCAT4 ZNF318 CACTIN SUPT4H1 OGT ANGEL1 DVL2 POLRMT RNF213 SIPA1 RFC4 OPA1 KIF7 SLC25A12 CSNK2A1 ARID2 CSNK2A2 PNMA2 MACF1 | 1.55e-06 | 1116 | 196 | 21 | 31753913 | |
| Pubmed | 1.75e-06 | 5 | 196 | 3 | 10698974 | ||
| Pubmed | RPL29 ADAR FASN BYSL MED17 MYBBP1A MRPS28 IARS1 ANGEL1 POLRMT RFC4 OPA1 POLR3A SLC3A2 ORC2 ARHGDIA LRPPRC SLC25A12 CSNK2A1 CSNK2A2 IQCB1 PNMA2 MPHOSPH6 | 2.12e-06 | 1335 | 196 | 23 | 29229926 | |
| Pubmed | IQGAP2 STRBP ASH1L LPCAT4 ZNF318 NEB PGAM2 ABCB1 FASN DST SCN9A METTL25 FLNC MYBBP1A LEO1 DNAH2 MAGI3 SLC3A2 LRPPRC GRPEL1 SLC25A12 DGKK MACF1 PLCH1 | 2.27e-06 | 1442 | 196 | 24 | 35575683 | |
| Pubmed | ADAR AP1M1 IARS1 RFC4 OPA1 SLC3A2 NSUN5 LSR LRPPRC CSNK2A1 MAP2K2 | 2.52e-06 | 323 | 196 | 11 | 24797263 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DDX19A RPL29 SPC25 SCYL1 FASN BYSL AP1M1 PUS7 USP47 FLNC OGT LEO1 IARS1 DVL2 SHMT2 IDE RFC4 PAPSS2 GRPEL1 CSNK2A1 CSNK2A2 PNMA2 MACF1 ENO2 | 2.65e-06 | 1455 | 196 | 24 | 22863883 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | DDX19A IQGAP2 STRBP ADAR FASN AP1M1 UTP20 MYBBP1A POLR1A POLRMT SHMT2 RFC4 POLR3A NSUN5 SLC25A12 PRKCI | 2.79e-06 | 704 | 196 | 16 | 29955894 |
| Pubmed | Colonic hamartoma development by anomalous duplication in Cdx2 knockout mice. | 3.48e-06 | 6 | 196 | 3 | 10383162 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RPL29 ACAA1 ASH1L FASN DST DOCK2 ARMT1 FLNC MYBBP1A IARS1 SHMT2 PAPSS2 ZNF169 SLC3A2 ARHGDIA LRPPRC MACF1 | 3.72e-06 | 807 | 196 | 17 | 30575818 |
| Pubmed | EPHB4 PIEZO1 CACTIN SBF1 BYSL PUS7 TIGAR MYBBP1A MRPS28 POLE2 DNAJC30 POLRMT SHMT2 SLC3A2 KIF7 LSR LRPPRC GRPEL1 GUSB RRP9 PPP1R15B MACF1 PRKCI PLCH1 | 3.83e-06 | 1487 | 196 | 24 | 33957083 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EPO RPL29 IQGAP2 CACTIN EHF ARMT1 MYBBP1A OGT IARS1 SHMT2 RFC4 PAPSS2 OPA1 SLC3A2 KPTN ARHGDIA LSR LRPPRC SLC25A12 CSNK2A1 CSNK2A2 PNMA2 | 3.91e-06 | 1284 | 196 | 22 | 17353931 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DDX19A SCYL1 SPTBN5 DST BYSL MIEF2 USP47 MYBBP1A PDSS2 MRPS28 ANGEL1 POLRMT SHMT2 RNF213 IDE OPA1 POLR3A LRPPRC GRPEL1 SLC25A12 RRP9 ARID2 PPP1R15B PRKCI | 4.24e-06 | 1496 | 196 | 24 | 32877691 |
| Pubmed | CAPN9 EPHB4 ERBB3 STRBP MAPK12 DNAH2 SHMT2 GIPC3 POLR3A GALNT11 CSNK2A1 CSNK2A2 DGKK PRKCI MAP2K2 KLK13 | 4.42e-06 | 730 | 196 | 16 | 34857952 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SPC25 PGAM2 XAB2 FASN BYSL AP1M1 PGP PUS7 TIGAR MYBBP1A OGT MRPS28 LEO1 IARS1 SHMT2 RFC4 PAPSS2 OPA1 SLC3A2 LRPPRC CSNK2A1 CSNK2A2 MACF1 | 5.52e-06 | 1415 | 196 | 23 | 28515276 |
| Pubmed | Perivascular neurons instruct 3D vascular lattice formation via neurovascular contact. | 6.07e-06 | 7 | 196 | 3 | 38733989 | |
| Pubmed | Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells. | 6.07e-06 | 7 | 196 | 3 | 10806215 | |
| Pubmed | A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. | 6.07e-06 | 7 | 196 | 3 | 11239457 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ZMYND19 IQGAP2 VPS45 SCYL1 ITGAV METTL25 FOXJ1 MYBBP1A OGT MRPS28 LEO1 INPP5E IARS1 SHMT2 RFC4 OPA1 KIF7 ARHGDIA LRPPRC CSNK2A1 IQCB1 PRKCI | 6.13e-06 | 1321 | 196 | 22 | 27173435 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX19A RPL29 ADAR FASN BYSL AP1M1 UTP20 MYBBP1A POLR1A IARS1 POLRMT SHMT2 IDE RFC4 OPA1 POLR3A SLC3A2 ARHGDIA LRPPRC RRP9 CSNK2A1 CSNK2A2 PRKCI | 6.19e-06 | 1425 | 196 | 23 | 30948266 |
| Pubmed | RPL29 IQGAP2 INPP4A VPS45 FASN DST SBF1 FLNC MYBBP1A OGT IARS1 SIPA1 SPECC1 OPA1 SLC3A2 ARHGDIA LRPPRC SLC25A12 CSNK2A1 CSNK2A2 MACF1 PLCH1 ENO2 | 6.63e-06 | 1431 | 196 | 23 | 37142655 | |
| Pubmed | RPL29 ADAR XAB2 FASN UTP20 MYBBP1A POLR1A IARS1 POLRMT RFC4 SLC3A2 NSUN5 RRP9 ARID2 CSNK2A2 MPHOSPH6 CSNK2A3 | 7.01e-06 | 847 | 196 | 17 | 35850772 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 7.43e-06 | 232 | 196 | 9 | 25515538 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | SDHAF1 ACAA1 SLC25A30 ABCB1 FASN PDSS2 MRPS28 DNAJC30 ADCK1 POLRMT SHMT2 IDE CPT1B OPA1 LRPPRC GRPEL1 SLC25A12 ABCB8 SLC25A44 | 8.35e-06 | 1047 | 196 | 19 | 18614015 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 DST DENND1B SBF1 SUPT4H1 AP1M1 MRPS28 INPP5E MAGI3 SPECC1 LSR LRPPRC IQCB1 MACF1 PRKCI PLCH1 MAP2K2 | 8.68e-06 | 861 | 196 | 17 | 36931259 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL29 IQGAP2 ADAR PHKA2 FASN DST FLNC MYBBP1A OGT MRPS28 IARS1 SHMT2 RFC4 ARHGDIA LRPPRC CSNK2A1 CSNK2A2 IQCB1 MACF1 ENO2 | 8.80e-06 | 1149 | 196 | 20 | 35446349 |
| Pubmed | 9.52e-06 | 24 | 196 | 4 | 19616115 | ||
| Pubmed | 9.67e-06 | 8 | 196 | 3 | 12393879 | ||
| Pubmed | SCYL1 CACTIN MED17 PDSS2 MRPS28 LEO1 IARS1 POLE2 RFC4 OPA1 POLR3A MPHOSPH6 | 1.09e-05 | 451 | 196 | 12 | 30033366 | |
| Pubmed | ZMYND19 IQGAP2 ASH1L ZNF318 ITGA9 AREL1 SUPT4H1 ARMT1 OGFRL1 MYBBP1A OGT INPP5E ANGEL1 SHMT2 FCHO2 TGFBR1 CSNK2A2 MACF1 NLRP4 | 1.36e-05 | 1084 | 196 | 19 | 11544199 | |
| Pubmed | TMTC2 FBXW8 DST AP1M1 MYBBP1A POLRMT SIPA1 SPECC1 LRPPRC SLC25A12 RRP9 ARID2 CSNK2A2 MACF1 | 1.64e-05 | 634 | 196 | 14 | 34591612 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | RPL29 ACAA1 DST MYBBP1A JAKMIP3 POLR3A SLC3A2 LRPPRC CSNK2A1 CSNK2A2 | 1.94e-05 | 329 | 196 | 10 | 34316702 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DDX19A RPL29 ADAR XAB2 CACTIN FASN AP1M1 MYBBP1A OGT POLR1A IARS1 DVL2 SHMT2 OPA1 ORC2 LRPPRC SLC25A12 RRP9 CSNK2A1 CSNK2A2 MAP2K2 | 1.95e-05 | 1318 | 196 | 21 | 30463901 |
| Pubmed | 2.07e-05 | 202 | 196 | 8 | 24639526 | ||
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | ACAA1 SLC25A30 FASN PDSS2 MRPS28 DNAJC30 ADCK1 POLRMT SHMT2 IDE CPT1B OPA1 LRPPRC GRPEL1 SLC25A12 ABCB8 SLC25A44 | 2.20e-05 | 926 | 196 | 17 | 20877624 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RPL29 ZNF318 ADAR XAB2 FASN DST CFDP1 PUS7 MYBBP1A DVL2 SHMT2 RFC4 SLC3A2 ORC2 ARHGDIA ARID2 MACF1 | 2.45e-05 | 934 | 196 | 17 | 33916271 |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 2.62e-05 | 272 | 196 | 9 | 25315684 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RPL29 ADAR PGAM2 AP1M1 FLNC POLR1A LEO1 IARS1 DNAH2 IDE POLR3A ARHGDIA NSUN5 LRP5 MACF1 ENO2 | 2.75e-05 | 847 | 196 | 16 | 35235311 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | IQGAP2 STRBP ADAR BYSL UTP20 MED17 MYBBP1A POLR1A POLRMT RFC4 NSUN5 RRP9 ARID2 IQCB1 MACF1 | 2.95e-05 | 759 | 196 | 15 | 35915203 |
| Pubmed | 3.13e-05 | 214 | 196 | 8 | 22199357 | ||
| Pubmed | Casein kinase 2 and microtubules control axon initial segment formation. | 3.16e-05 | 2 | 196 | 2 | 20850541 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 11002341 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 37820892 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 11704824 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 21739153 | ||
| Pubmed | Uncoupling of inhibitory and shuttling functions of rho GDP dissociation inhibitors. | 3.16e-05 | 2 | 196 | 2 | 15513926 | |
| Pubmed | Fatty acid synthase inhibits the O-GlcNAcase during oxidative stress. | 3.16e-05 | 2 | 196 | 2 | 28232487 | |
| Pubmed | The role of PIEZO ion channels in the musculoskeletal system. | 3.16e-05 | 2 | 196 | 2 | 36717101 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 33781748 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 1497660 | ||
| Pubmed | A Plug-and-Latch Mechanism for Gating the Mechanosensitive Piezo Channel. | 3.16e-05 | 2 | 196 | 2 | 32142647 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 25089713 | ||
| Pubmed | LRPPRC contributes to the cisplatin resistance of lung cancer cells by regulating MDR1 expression. | 3.16e-05 | 2 | 196 | 2 | 33649818 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 21761202 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 28362255 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 34046694 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 10350657 | ||
| Pubmed | Assignment of casein kinase 2 alpha sequences to two different human chromosomes. | 3.16e-05 | 2 | 196 | 2 | 1577469 | |
| Pubmed | CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo. | 3.16e-05 | 2 | 196 | 2 | 26598688 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 21056836 | ||
| Pubmed | Myeloid Cell CK2 Regulates Inflammation and Resistance to Bacterial Infection. | 3.16e-05 | 2 | 196 | 2 | 33363536 | |
| Pubmed | Nox2-containing NADPH oxidase and xanthine oxidase are sources of superoxide in mouse trachea. | 3.16e-05 | 2 | 196 | 2 | 19076165 | |
| Pubmed | Astrocytes in the optic nerve head express putative mechanosensitive channels. | 3.16e-05 | 2 | 196 | 2 | 26236150 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 7896000 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 38272384 | ||
| Pubmed | Axonal and Glial PIEZO1 and PIEZO2 Immunoreactivity in Human Clitoral Krause's Corpuscles. | 3.16e-05 | 2 | 196 | 2 | 38928429 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 30628892 | ||
| Pubmed | Piezo1 ion channel pore properties are dictated by C-terminal region. | 3.16e-05 | 2 | 196 | 2 | 26008989 | |
| Pubmed | Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. | 3.16e-05 | 2 | 196 | 2 | 20813920 | |
| Pubmed | Structural basis of CX-4945 binding to human protein kinase CK2. | 3.16e-05 | 2 | 196 | 2 | 21093442 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 16054116 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 18703598 | ||
| Pubmed | [Feeling the pressure? Identification of two proteins activated by mechanical forces]. | 3.16e-05 | 2 | 196 | 2 | 21299953 | |
| Pubmed | Specific localization of the catalytic subunits of protein kinase CK2 at the centrosomes. | 3.16e-05 | 2 | 196 | 2 | 12568341 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 38395907 | ||
| Pubmed | Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development. | 3.16e-05 | 2 | 196 | 2 | 38395992 | |
| Pubmed | Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2. | 3.16e-05 | 2 | 196 | 2 | 14646071 | |
| Pubmed | Mechanisms of mechanotransduction and physiological roles of PIEZO channels. | 3.16e-05 | 2 | 196 | 2 | 39251883 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 37975162 | ||
| Pubmed | Transduction of Repetitive Mechanical Stimuli by Piezo1 and Piezo2 Ion Channels. | 3.16e-05 | 2 | 196 | 2 | 28636944 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 10970045 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 25037583 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 16947382 | ||
| Pubmed | Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. | 3.16e-05 | 2 | 196 | 2 | 12860116 | |
| Pubmed | Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes. | 3.16e-05 | 2 | 196 | 2 | 21769451 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 27017927 | ||
| Interaction | RAC1 interactions | CYBB EPHB4 RPL29 IQGAP2 STRBP VPS45 ITGAV FASN DST SBF1 UTP20 DOCK2 RASGRF1 DVL2 FCHO2 SIPA1 SPECC1 SLC3A2 TGFBR1 ARHGDIA ARHGDIG LSR LRPPRC CSNK2A2 IQCB1 LRP5 MACF1 PRKCI MAP2K2 | 3.43e-07 | 1063 | 193 | 29 | int:RAC1 |
| Interaction | CCDC8 interactions | DDX19A ZNF318 FASN FBXW8 DST UTP20 MYBBP1A MRPS28 POLR1A IARS1 DVL2 SPECC1 SLC3A2 KIF7 ARHGDIA LSR LRPPRC CSNK2A1 PNMA2 MACF1 | 5.28e-06 | 656 | 193 | 20 | int:CCDC8 |
| Cytoband | 7q11.23 | 6.32e-05 | 97 | 196 | 5 | 7q11.23 | |
| Cytoband | 17p13.1 | 1.60e-04 | 118 | 196 | 5 | 17p13.1 | |
| Cytoband | 22q13.33 | 5.79e-04 | 38 | 196 | 3 | 22q13.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp22 | 7.57e-04 | 250 | 196 | 6 | chrXp22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 7.63e-04 | 346 | 196 | 7 | chr17p13 | |
| Cytoband | 2q24 | 9.72e-04 | 11 | 196 | 2 | 2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 1.15e-03 | 271 | 196 | 6 | chr7q11 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-07 | 182 | 196 | 9 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-07 | 182 | 196 | 9 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-07 | 182 | 196 | 9 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-06 | 178 | 196 | 8 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-06 | 181 | 196 | 8 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.42e-06 | 194 | 196 | 8 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.42e-06 | 194 | 196 | 8 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| ToppCell | Healthy_donor-cDC|World / disease group, cell group and cell class (v2) | 2.71e-06 | 197 | 196 | 8 | a545fe3a80cd721bf01115bbb645753840ec9f40 | |
| ToppCell | Healthy-cDC|World / disease group, cell group and cell class | 2.82e-06 | 198 | 196 | 8 | 8976f8d26cb7ff79f74def138c4bbbb0bc2eaf00 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 6.02e-06 | 156 | 196 | 7 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 6.02e-06 | 156 | 196 | 7 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, Lineage and Cell Type | 8.69e-06 | 165 | 196 | 7 | 8728f927502e56f2768b4224e9111939d3d7815a | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 171 | 196 | 7 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-05 | 172 | 196 | 7 | 1abb6fbb28c8aff384540493d0f70eeacaa751f4 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-05 | 172 | 196 | 7 | 422d311bba2dd5d8bece4e96ee8c86e78086b62d | |
| ToppCell | Tuft-tuft-4|World / Class top | 1.23e-05 | 174 | 196 | 7 | d6f306ebf66061bf9e9742000bfedce12d277452 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.32e-05 | 176 | 196 | 7 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | ILEUM-inflamed-(3)_pDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.32e-05 | 176 | 196 | 7 | b9f847dd55703e413f3cd815eef5724fffaf13b3 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-05 | 179 | 196 | 7 | 6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 183 | 196 | 7 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-05 | 186 | 196 | 7 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Chrna6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.93e-05 | 125 | 196 | 6 | fac8a9bff83abb8976013ff7d2b4ce0b68fbb70a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.96e-05 | 187 | 196 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 2.02e-05 | 188 | 196 | 7 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | control-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.09e-05 | 189 | 196 | 7 | bdfd120900ba58d5e54765f7b576e1f8cc2401bf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 189 | 196 | 7 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 190 | 196 | 7 | ee7b60cdf93c695ea2d59a170ca8cf4dc93e7eb2 | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 2.24e-05 | 191 | 196 | 7 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 192 | 196 | 7 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 2.32e-05 | 192 | 196 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 196 | 7 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-05 | 194 | 196 | 7 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | (010)_cDC|World / immune cells in Peripheral Blood (logTPM normalization) | 2.56e-05 | 195 | 196 | 7 | 4aabb3f5ce70100e4d98d7fa9f8d12e84fb9fe3d | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.56e-05 | 195 | 196 | 7 | dd28c63b53f2a97e3fac127294a465870dc371b3 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-05 | 195 | 196 | 7 | d6ff38535898f90be6719cd5152291f2f4f8a746 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid-Microglia|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.64e-05 | 196 | 196 | 7 | 89a0ccd0684777927d99d5fc5b7c498f3f124250 | |
| ToppCell | PBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.64e-05 | 196 | 196 | 7 | e1f763fa9c11bf5f4d80e79f70f9485724ac23fe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.64e-05 | 196 | 196 | 7 | 889c9fed857f64664ca1f47fcec9fecb15ed103c | |
| ToppCell | PBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.64e-05 | 196 | 196 | 7 | d376168e15ec1cf618723259966c76be3698b9b0 | |
| ToppCell | Control-Myeloid-cDC|Control / Disease group, lineage and cell class | 2.64e-05 | 196 | 196 | 7 | 85d92bc226cc28384c30991cc4ebb02ec2e3ec99 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.64e-05 | 196 | 196 | 7 | 91a8c4798572d6c1f03cef5e8e5464ed0046c7cf | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.64e-05 | 196 | 196 | 7 | 553c22c7d48f3b4f6f2b2f10d6e668c5ebb09e8c | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.64e-05 | 196 | 196 | 7 | 4a9095ba3f6709f88f32bf09184553f4bd211f43 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.73e-05 | 197 | 196 | 7 | e567f91fa398fd306d025dcfe89bd50a60216537 | |
| ToppCell | mild_COVID-19-cDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.73e-05 | 197 | 196 | 7 | 44ebd3f967779bb7753fc6dcd9fde6d682f9ccd6 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 2.73e-05 | 197 | 196 | 7 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 2.82e-05 | 198 | 196 | 7 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 198 | 196 | 7 | 0a4626b51ba8b52acbaf616f0ced850079cd7149 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.82e-05 | 198 | 196 | 7 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease, condition lineage and cell class | 2.82e-05 | 198 | 196 | 7 | 033ed362333e1d33f2aeea8da5865d2228d154dc | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.82e-05 | 198 | 196 | 7 | 35499a5231818e3432cf69b5c4a58c02f7771db8 | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.91e-05 | 199 | 196 | 7 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, condition lineage and cell class | 2.91e-05 | 199 | 196 | 7 | a2be40d367338d32348a6906c8475aa3b544a0f7 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 2.91e-05 | 199 | 196 | 7 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.91e-05 | 199 | 196 | 7 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-05 | 199 | 196 | 7 | 994e885b8d1874006302a081d13f1ee881d64612 | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 2.91e-05 | 199 | 196 | 7 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease, condition lineage and cell class | 2.91e-05 | 199 | 196 | 7 | 9de61e5189d907cc969ac3043d68204f70acc0bf | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.01e-05 | 200 | 196 | 7 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | Control-Control-Myeloid-cDC|Control / Disease, condition lineage and cell class | 3.01e-05 | 200 | 196 | 7 | 1375d199320feb85ba06e74b10df6521e790addf | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.01e-05 | 200 | 196 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | COVID-mono1-|COVID / Condition, Cell_class and T cell subcluster | 3.01e-05 | 200 | 196 | 7 | 445a1aab962673dcc926c33ce9bed5ede9c41c57 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.01e-05 | 200 | 196 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.01e-05 | 200 | 196 | 7 | c8b80d4e7f70c66cbbdd0665821bcd5db69c7d35 | |
| ToppCell | COVID|World / Condition, Cell_class and T cell subcluster | 3.01e-05 | 200 | 196 | 7 | 04a932fe2431e7886120c219ce666f90d3030a1c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.01e-05 | 200 | 196 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | COVID-mono1|COVID / Condition, Cell_class and T cell subcluster | 3.01e-05 | 200 | 196 | 7 | bd002c54305c746c07b7418a2084195e9c852ec5 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-cDC|COVID-19_Severe / Disease, condition lineage and cell class | 3.01e-05 | 200 | 196 | 7 | e7b808d8ed65343a4345fafb03015fe4f7ce302f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-05 | 200 | 196 | 7 | 4b1ae9f71f0fe998b06fa580885572d1fc1544e2 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 3.01e-05 | 200 | 196 | 7 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-05 | 146 | 196 | 6 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 146 | 196 | 6 | 69cbe8d4772f8e46a5e1a1cdca0e370308a97b4f | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.58e-05 | 151 | 196 | 6 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_C|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.58e-05 | 151 | 196 | 6 | 3f2abaa42876ce7a71d934ff16abe0cab0991a05 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.45e-05 | 155 | 196 | 6 | ab539c04f10276ae919d82b1c75f99a84eb695bf | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.45e-05 | 155 | 196 | 6 | 9a27558c457f05808af07190b7a5006b047f1d58 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.69e-05 | 156 | 196 | 6 | 84f01419d8c116714e8c8c857c4d153a755b7867 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.69e-05 | 156 | 196 | 6 | 2285be9746d0d0f62a488b9c64fa67a834758dd7 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.69e-05 | 160 | 196 | 6 | 9f1fec2cf565193c73cc3c8a4f0476e57478e3b8 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.82e-05 | 164 | 196 | 6 | cfe07a1ebed8aecb08d0476db71fe314998d54aa | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.82e-05 | 164 | 196 | 6 | 6d331e74efecb4733d87653f86cd67247be05025 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 165 | 196 | 6 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 165 | 196 | 6 | 0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 165 | 196 | 6 | e32697321cef424c2ad4e11ee9da3e510d5ce505 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.11e-05 | 165 | 196 | 6 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.11e-05 | 165 | 196 | 6 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-05 | 166 | 196 | 6 | 8ab18c9d911eb3a9970bba7a769294b0927538f7 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-05 | 167 | 196 | 6 | e30e7ac8ea4399dc3c1d94fc6b857afc80a7a671 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.74e-05 | 167 | 196 | 6 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.74e-05 | 167 | 196 | 6 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 168 | 196 | 6 | dd48da83c32d41a62f80cd7e5e5c64e42776fa27 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 168 | 196 | 6 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 168 | 196 | 6 | dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 169 | 196 | 6 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 170 | 196 | 6 | 749144a1a869a6bf9acdd227184319083367dc3f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.07e-04 | 170 | 196 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Immune_cells-Dendritic_cells|World / Lineage and Cell class | 1.07e-04 | 170 | 196 | 6 | 094dc211d80c89ecb1010855f1fe6eeb71bf0e20 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 170 | 196 | 6 | 25d60a62e8f99c31ab64fe6a0c07ccca3df1a7ee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 171 | 196 | 6 | af1c93eb75f45c042ea475d93db56e4da207e31f | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.14e-04 | 172 | 196 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| Drug | Glucose | CYBB CCDC60 RPL29 ERBB3 ERN1 IQGAP2 STRBP HUNK KDM6B ABCB1 FASN PIGA CFDP1 BYSL AP1M1 OGT LEO1 XDH SI IDE FCHO2 OPA1 TGFBI TGFBR1 LSR RNASEL SLC25A12 GUSB ARID2 MAP2K2 ENO2 | 1.61e-06 | 1420 | 196 | 31 | ctd:D005947 |
| Disease | Malignant neoplasm of breast | EPHB4 MAGEA1 ERBB3 STRBP ZNF318 ITGA9 ALS2CL ADAR ABCB1 FASN AP1M1 UTP20 CNR2 MRPS28 XDH JAKMIP3 RFC4 SLC5A5 ARHGDIA ARAP3 CSF2 TMTC4 RRP9 ABCB8 MACF1 | 4.15e-08 | 1074 | 193 | 25 | C0006142 |
| Disease | Headache | 6.34e-05 | 64 | 193 | 5 | HP_0002315 | |
| Disease | chronic obstructive pulmonary disease, coronary artery disease | 2.53e-04 | 4 | 193 | 2 | EFO_0000341, EFO_0001645 | |
| Disease | Deep Vein Thrombosis | 3.36e-04 | 21 | 193 | 3 | C0149871 | |
| Disease | Venous Thrombosis | 3.36e-04 | 21 | 193 | 3 | C0042487 | |
| Disease | Metastatic melanoma | 4.35e-04 | 54 | 193 | 4 | C0278883 | |
| Disease | Malignant neoplasm of skin | 6.10e-04 | 59 | 193 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 6.10e-04 | 59 | 193 | 4 | C0037286 | |
| Disease | Congestive heart failure | 7.98e-04 | 110 | 193 | 5 | C0018802 | |
| Disease | Heart failure | 7.98e-04 | 110 | 193 | 5 | C0018801 | |
| Disease | Left-Sided Heart Failure | 7.98e-04 | 110 | 193 | 5 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 7.98e-04 | 110 | 193 | 5 | C0235527 | |
| Disease | Heart Decompensation | 7.98e-04 | 110 | 193 | 5 | C1961112 | |
| Disease | Myocardial Failure | 7.98e-04 | 110 | 193 | 5 | C1959583 | |
| Disease | peritonitis (biomarker_via_orthology) | 8.75e-04 | 7 | 193 | 2 | DOID:8283 (biomarker_via_orthology) | |
| Disease | Thrombocytopenia | 8.88e-04 | 29 | 193 | 3 | C0040034 | |
| Disease | melanoma | 1.29e-03 | 248 | 193 | 7 | C0025202 | |
| Disease | post-operative acute kidney injury | 1.49e-03 | 9 | 193 | 2 | EFO_0009955 | |
| Disease | Thyroid Gland Follicular Adenoma | 1.55e-03 | 35 | 193 | 3 | C0151468 | |
| Disease | Thyroid Neoplasm | 1.82e-03 | 37 | 193 | 3 | C0040136 | |
| Disease | Short Stature, CTCAE | 1.85e-03 | 10 | 193 | 2 | C2919142 | |
| Disease | Short stature | 1.85e-03 | 10 | 193 | 2 | C0349588 | |
| Disease | Liver carcinoma | MAGEA1 EPO IQGAP2 CLTRN SPC25 ABCB1 FASN SLC5A5 IGFALS ARID2 | 1.96e-03 | 507 | 193 | 10 | C2239176 |
| Disease | schizophrenia, intelligence, self reported educational attainment | 2.09e-03 | 346 | 193 | 8 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Profound Mental Retardation | 2.25e-03 | 139 | 193 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.25e-03 | 139 | 193 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.25e-03 | 139 | 193 | 5 | C0917816 | |
| Disease | Moyamoya disease | 2.28e-03 | 40 | 193 | 3 | MONDO_0016820 | |
| Disease | Mammary Carcinoma, Human | 2.52e-03 | 525 | 193 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.52e-03 | 525 | 193 | 10 | C1257931 | |
| Disease | Mammary Neoplasms | 2.59e-03 | 527 | 193 | 10 | C1458155 | |
| Disease | Pulmonary Thromboembolisms | 2.69e-03 | 12 | 193 | 2 | C0524702 | |
| Disease | Parkinson Disease, Secondary Vascular | 2.69e-03 | 12 | 193 | 2 | C0751414 | |
| Disease | Atherosclerotic Parkinsonism | 2.69e-03 | 12 | 193 | 2 | C0751415 | |
| Disease | Pulmonary Embolism | 2.69e-03 | 12 | 193 | 2 | C0034065 | |
| Disease | Secondary Parkinson Disease | 2.69e-03 | 12 | 193 | 2 | C0030569 | |
| Disease | Mitral valve prolapse, response to surgery | 2.69e-03 | 12 | 193 | 2 | EFO_0009951, HP_0001634 | |
| Disease | Intellectual Disability | 2.85e-03 | 447 | 193 | 9 | C3714756 | |
| Disease | Thyroid carcinoma | 3.00e-03 | 44 | 193 | 3 | C0549473 | |
| Disease | Breast Carcinoma | 3.00e-03 | 538 | 193 | 10 | C0678222 | |
| Disease | Gastric Adenocarcinoma | 3.19e-03 | 45 | 193 | 3 | C0278701 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 3.68e-03 | 14 | 193 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | glucose measurement | 3.69e-03 | 380 | 193 | 8 | EFO_0004468 | |
| Disease | Kidney Failure, Chronic | 3.84e-03 | 48 | 193 | 3 | C0022661 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 4.12e-03 | 160 | 193 | 5 | DOID:5844 (biomarker_via_orthology) | |
| Disease | pulse pressure measurement | EPHB4 TET2 EPO SPC25 ZNF318 KDM6B ITGA9 ARID5A AREL1 FASN DENND1B PXDNL CFDP1 MARVELD3 RNF213 SIPA1 PIEZO2 MAP2K2 | 4.68e-03 | 1392 | 193 | 18 | EFO_0005763 |
| Disease | Glycogen storage disease | 5.43e-03 | 17 | 193 | 2 | cv:C0017919 | |
| Disease | Uremia | 5.43e-03 | 17 | 193 | 2 | C0041948 | |
| Disease | nephrotic syndrome (is_marker_for) | 6.08e-03 | 18 | 193 | 2 | DOID:1184 (is_marker_for) | |
| Disease | migraine disorder, systolic blood pressure | 6.08e-03 | 18 | 193 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | mean corpuscular hemoglobin concentration | IQGAP2 PIEZO1 ZNF318 NEB BYSL CACNA1I MED17 POLR1A FCHO2 SPECC1 LMO2 LRP5 MACF1 ENO2 ADAP2 | 6.26e-03 | 1105 | 193 | 15 | EFO_0004528 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ETLGGKKLRVFVYRN | 456 | Q15582 | |
| AAYRGLLRVALERKG | 726 | Q60I27 | |
| LILFKGDLNYRKLTG | 361 | Q9H993 | |
| LGFRSLKEISAGRIY | 441 | P21860 | |
| KRVKEYSQRLGAGDL | 366 | Q86TW2 | |
| VGRELTRKKGILLQY | 1161 | Q9HCE6 | |
| VEKLGAYELVTGRRL | 96 | Q03989 | |
| LESLKRYRFGKDAVG | 1511 | Q9NR48 | |
| FDYRLAGDKVGKLRV | 466 | Q8IUX8 | |
| GEFISRKYRLGLFRK | 591 | Q8WWN8 | |
| KKLLGDYIGIRLREN | 11 | Q0P641 | |
| ELVGTGYRLSLIKKR | 786 | Q0JRZ9 | |
| GYRLSLIKKRFATGR | 791 | Q0JRZ9 | |
| IALSKYGRVKRGSKV | 181 | P10767 | |
| YANGAARLTALRIKK | 466 | Q8NER5 | |
| LKNIGKYSECGRRLL | 1776 | Q68CP9 | |
| LKGKVLICRNYRGDV | 11 | Q9BXS5 | |
| LLLRRKKPYGAISHG | 601 | P51693 | |
| LAREYGGSKRNALLK | 956 | Q5M775 | |
| GLGKLEYLLLSRNRL | 456 | P35858 | |
| LRGLLLRGEAIKYLT | 16 | P56282 | |
| AGYAFIKRIKEGSII | 131 | Q8TF64 | |
| AGEKLGKEARSLYER | 526 | O94923 | |
| SGKRKVYLLSLLLIG | 11 | P01008 | |
| CTGLLKLYGDRRKFL | 451 | Q9NUG4 | |
| GRLDYAKLRERIKAG | 341 | Q86YH6 | |
| YALLRKSKERQGLDG | 341 | O43286 | |
| ALELRDGDKQRYLGK | 46 | P09104 | |
| ERREARKYASGLLKA | 471 | O14641 | |
| RGLVSLSAKIDRKGY | 181 | Q8TBH0 | |
| RRKFVLLAREGLLKY | 151 | Q9NPF8 | |
| GRGYFAILREETAKK | 66 | Q8IWA6 | |
| YKALLTRGRALVTLG | 141 | P34972 | |
| GKVSIAVLRGLAYLR | 171 | P36507 | |
| EVGRRLYYKLGRKLC | 66 | P25791 | |
| RSGLIFYRKGVKAVD | 286 | P34897 | |
| LGIRSKYASLRKDTL | 206 | Q96PE3 | |
| AKVLVYELLLGKGFR | 71 | Q96P11 | |
| GLKVYLGKHALGRVE | 81 | Q9UKR3 | |
| TFGKAGEILTKRLRY | 776 | P08183 | |
| YGARTKEIRSRLLKL | 296 | Q9H346 | |
| ESRDVKGLYKRARAG | 156 | O95340 | |
| GLLGTKELLQRSYRK | 896 | Q5KSL6 | |
| YLRITRILKSLGELG | 236 | Q5TC84 | |
| SLAAIKNRYKGGIRE | 586 | Q8WVC0 | |
| LLRVIGRGSYAKVLL | 256 | P41743 | |
| GRGSYAKVLLVRLKK | 261 | P41743 | |
| GFLLLKYRAREPVTK | 111 | P43355 | |
| AKLLEGKSRRIAGYT | 1306 | Q5TCQ9 | |
| KVLRKAGLSAGYVDA | 331 | Q643R3 | |
| RAELRGLKRGASYLV | 491 | P54760 | |
| AGKFDRELYLLGIKR | 606 | Q9NRR6 | |
| YERSRGKLIGAKDVQ | 826 | Q86VF7 | |
| KVGYKLHGRTLRPAL | 196 | Q9HAV7 | |
| RLRDLEGIGKSLKYY | 1281 | Q03001 | |
| SFLDYVRRSLKKLGL | 506 | Q8N6Q8 | |
| RTGGKRKEILSALYS | 266 | O75197 | |
| DLKKEILINVGGRRY | 56 | Q8TDN1 | |
| RESLVRAGKKIAYQG | 1551 | O15054 | |
| KSYRKRRALLIGSLL | 71 | Q8IWD5 | |
| GSKILVYSLEAGRRL | 411 | Q8N3Y1 | |
| LLAATLKGKVLGFRY | 41 | Q9Y664 | |
| SKTRAAYAEKLRRLG | 71 | A6NDG6 | |
| YGNISERVELRKKLG | 426 | Q8NCW6 | |
| GKRLDYLNLKGARLT | 161 | Q8N4B4 | |
| TIDARAAGKGDLKLY | 691 | Q14315 | |
| YRDSKITRILKDSLG | 301 | Q2M1P5 | |
| AGYVKSVLERDKLLR | 421 | Q5VZ66 | |
| LDTGKYVGLVRVLAK | 746 | P42704 | |
| ALLGTKILLKYGERE | 431 | Q96MN2 | |
| LRKVGDKILGDLSYR | 196 | Q9NVC6 | |
| ETLKSLGRYRLLGKI | 41 | Q9UL42 | |
| LGRYRLLGKIFRKQE | 46 | Q9UL42 | |
| LDDAKARLRKYDIGG | 16 | P0C024 | |
| LTARVKGGDGIRIYK | 81 | Q9NZU5 | |
| TLGRVEDFYRKLKGL | 5231 | Q9UPN3 | |
| KYALKRLITGLGVGR | 71 | Q9BQG0 | |
| ALYILGDKAQLKGVR | 1326 | O95248 | |
| ELRQGLYKVLRLGVK | 306 | Q8NGI1 | |
| RLLKLRYLILGSAVG | 96 | O60313 | |
| DKGIGKVYIFRADRR | 271 | Q13797 | |
| RQKLRKLYGSPGDID | 1181 | A1KZ92 | |
| RGKEGYIERKAFLDR | 266 | Q9UEE9 | |
| LVRKLGRGKYSEVFE | 41 | Q8NEV1 | |
| LELYKQGLRGSLTKL | 76 | P04141 | |
| RKLKELGVNGLIYDR | 596 | Q9NPB8 | |
| LVRIGREEGLKALYS | 56 | Q5SVS4 | |
| NLVKGLLEKLLDYRG | 1176 | Q92608 | |
| DLLRLSYGEAKKAAR | 1176 | P55265 | |
| ESLRKYKEALLGRVA | 46 | P52565 | |
| DRSLAKYKRVLLGPL | 66 | Q99819 | |
| LRKFRTYKGGSVRDL | 886 | O75460 | |
| KFLSDLRLYGGRVFK | 411 | Q14CM0 | |
| LERVDGRRLVYKFGK | 276 | Q9NZC4 | |
| LGLDQKRRKYVVGEL | 571 | P08236 | |
| LRKAKRRALGLYQAL | 446 | Q9P0X4 | |
| VGRLDRGKSAILYVK | 916 | P06756 | |
| SSVKKRGVLLLGDAY | 396 | Q14534 | |
| KRVGNYLIGSRKLGE | 56 | P57058 | |
| LRGKLKLYTGEACRT | 176 | P01588 | |
| YAERLLSGAFKKRRL | 201 | Q92949 | |
| LAGLKGRLDYLSSLK | 241 | P08195 | |
| GRLDYLSSLKVKGLV | 246 | P08195 | |
| TVRKAGRYEITVKLG | 131 | O15033 | |
| QLVRKLGRGKYSEVF | 41 | P19784 | |
| LVRKLGRGKYSEVFE | 41 | P68400 | |
| LGAVLAIKGYRKVRK | 376 | Q96A59 | |
| ARKRIKNPEGGLYLA | 156 | P04839 | |
| SGDLLRIGRKALYSI | 196 | Q15051 | |
| RDGRAKPIDLLAKYI | 301 | Q8WUQ7 | |
| KREYRGLELANGIKV | 61 | P14735 | |
| LGSATLRRKYDRGLL | 101 | Q96LL9 | |
| LKLAYAVRGNKLERG | 191 | Q9NUU7 | |
| VNIRGKLVSLEKYRG | 31 | Q96SL4 | |
| LRLVGLKKSFYGSTL | 1386 | P49327 | |
| RKLKRFGANVLTIGY | 406 | O14815 | |
| ARLKRPLKSLDGALY | 506 | Q6P3S1 | |
| KLLVRISGKRVYRDL | 761 | Q9P225 | |
| GLRALTSLLRYAGKK | 1976 | Q9P225 | |
| LKKRRVGDLLASYIP | 16 | Q9BWG6 | |
| VFGYLADRLGRRKVL | 151 | Q4U2R8 | |
| SKLLRDVYAKDGRVS | 371 | O00411 | |
| RGVREVLSKYRSGKL | 186 | Q13895 | |
| KRLIRIKNGILRGVY | 41 | Q92523 | |
| GLIRYISGLLRKKVE | 821 | P46019 | |
| YDGRLLEEAVRKKGS | 586 | Q86X29 | |
| PKDLKLSDGRLRVGY | 546 | O15294 | |
| LLKKGGLYAELIRRQ | 696 | Q9NUT2 | |
| TKEDLRYLRLRGGLL | 1276 | Q6ZN16 | |
| GYSEAAKKRITGFRL | 96 | Q99735 | |
| AKKRITGFRLSLGIL | 101 | Q99735 | |
| GGYLSSRVLLELLRK | 246 | Q96C03 | |
| IVLYGLGSKRDLLER | 311 | Q13416 | |
| PKGVSRKLDRLAYIA | 86 | P47914 | |
| KERRVTKAYLALLRG | 91 | Q9UJJ7 | |
| GEKYQKGTRVRLRLL | 131 | Q9Y2Q9 | |
| GKILGIKRSYLVAEV | 346 | Q9H0K4 | |
| LLLKDYAKLGAARGQ | 2161 | O75691 | |
| GIAYLVKVSEGDLRK | 226 | P35249 | |
| LTKFIARYGGRKLER | 561 | Q9HCS7 | |
| LNELKRRGKRAYGVV | 391 | P09110 | |
| RLRERKYGVVEGKAL | 86 | Q9NQ88 | |
| LVYRGLTDKVGRVKL | 656 | O95602 | |
| LAKRLYRLDGFRKAD | 561 | A5PKW4 | |
| IYLKARVEAGGLKEL | 101 | Q96KG9 | |
| RRYETLVGTIGKKFA | 116 | Q99547 | |
| EEGLRNGVYLAKLAK | 66 | Q13576 | |
| ISKERRYAGLKPGEL | 136 | P15259 | |
| KDGTRYTGIRSLKLD | 181 | O14793 | |
| KRCVEGQLLRGLSKY | 441 | Q96PZ0 | |
| LEDLGRLVLYVVKKG | 521 | Q05823 | |
| DYARLVKGRIEKTLL | 1096 | O14802 | |
| LRLVKGAKGIRTLLF | 1621 | Q15858 | |
| RGRALGAVDKYRLRK | 176 | Q8N196 | |
| LLGDVVRLKGFESYR | 366 | Q96FS4 | |
| KRRGLKYELISETGG | 521 | Q96SI9 | |
| LYEAAKVFGLRSRKL | 1211 | P41252 | |
| VLSLYRDLLRAGRGK | 11 | A6NFY7 | |
| ILKRGYINKSETRLG | 1756 | P14410 | |
| FIKILRADGITGLYR | 61 | Q96H78 | |
| KALKGLYGNRDLTAR | 66 | P0CL83 | |
| KLARALRNYAKTGEI | 226 | Q01892 | |
| GVYSALRALKGREKP | 101 | Q5SWA1 | |
| GLLARKDGTRKGYLS | 16 | Q13972 | |
| GIVRELKSRGVAYKS | 96 | P63272 | |
| KVYALRKLAGTLERG | 3161 | Q9NRC6 | |
| YANGAARLTALRIKK | 476 | P36897 | |
| RLGLEIRKIYGEKLQ | 141 | Q9HBM1 | |
| LYRDGTLKLLGRLSL | 621 | Q9UNK9 | |
| VLRDLGIFGLYKGAK | 471 | O75746 | |
| KSRGRLIDFKEIQYG | 511 | Q70JA7 | |
| KVRLSIRTALGDKAY | 26 | Q9HBJ8 | |
| VSRLVYRKGIDLLSG | 231 | P37287 | |
| SERAGVGKSLYVKRL | 1991 | Q63HN8 | |
| KTRLIKFLSDLRRGG | 2426 | Q63HN8 | |
| GTKENYGLLRRKLEL | 721 | Q5T4D3 | |
| KRRKKSVYTVGLRGL | 351 | Q70EK9 | |
| LGIVRLGRVAGKTKY | 6 | Q96E35 | |
| STLLKDRVKLGTDYR | 216 | P40200 | |
| YLGGLREQEKRIKCL | 1091 | Q9NZQ8 | |
| IGVILGAEAARRYKK | 321 | Q6ZMD2 | |
| RKLVIISKGLSLIYG | 381 | Q92911 | |
| GKYLASGDRSKLILI | 211 | O43818 | |
| KVLFTKETAGYLRGR | 341 | Q14159 | |
| LTYGKLLALTGRKSE | 681 | Q8N394 | |
| VDRALYLRKTVLGKV | 2246 | Q9H5I5 | |
| TIRLGRALKKGEYRV | 1111 | Q96K76 | |
| KALKGLYGNRDLTAR | 66 | P0CL84 | |
| KLVSAVVEYGGKRVR | 421 | Q9NRW7 | |
| LLAYLRRKLGLSGTK | 26 | P47989 | |
| LKRGTKGLVRLFYLD | 31 | Q4KWH8 | |
| TLGKYGAEVKLRRLL | 216 | Q7Z4N2 | |
| GKRYKRRLNLDTLLS | 686 | Q9UK10 | |
| EGLRRLLGKYKFRDL | 6 | Q8IX04 | |
| LEGRYRASLLKRGFK | 106 | O14904 | |
| KLYGKALSRLISFRR | 246 | Q8N8L2 | |
| KALKGLYGNRDLTAR | 66 | P0CL85 | |
| VVDRALYLRKTVLGK | 2016 | Q92508 | |
| KGKAIRIERVIYTGK | 1171 | Q6N021 | |
| LLRGTERNREKLKGY | 246 | Q5VUA4 | |
| AVIRGNYRLGLSKKS | 211 | Q14929 | |
| DGRTGAKVAIKKLYR | 46 | P53778 | |
| KVRGLKEGVSYVFRV | 1101 | P52179 | |
| YKRDLELEVKGRGLN | 6011 | P20929 |